Valley Brook Capital Group Inc. reduced its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,734 shares of the company’s stock after selling 233 shares during the quarter. Valley Brook Capital Group Inc.’s holdings in Colgate-Palmolive were worth $430,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at $36,000. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $53,000. Finally, Synergy Asset Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at $49,000. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
Shares of CL opened at $87.35 on Wednesday. The stock has a 50 day moving average of $90.14 and a 200 day moving average of $96.69. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.
Analyst Ratings Changes
Several brokerages have weighed in on CL. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Stifel Nicolaus dropped their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, Barclays dropped their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.16.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Canada Bond Market Holiday: How to Invest and Trade
- Citigroup Analysts Are Betting Big on These 3 Stocks—Should You?
- Dividend Payout Ratio Calculator
- Johnson Controls: 5 Reasons to Own This Engineering Giant
- Stock Average Calculator
- Constellation Brands: A Fallen Star or a Hidden Value Play?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.